Morningside Ventures Leads $15M Round In Luqa Pharma
June 10, 2015 — 17:07 CST
This Data Is Locked!
This area is available only to Subscribers.
Hong Kong-headquartered Luqa Pharmaceuticals, a dermatology specialty company, has completed US$15 million new round of financing led by Morningside Ventures, according to a company announcement.... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals